NCT01887197View on ClinicalTrials.gov

Repeatability and Response Study of Absorptive Clearance Scans

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

December 31, 2017

Study Completion Date

May 31, 2018

Conditions
Cystic Fibrosis
Interventions
OTHER

Absorptive clearance scan

Subjects inhale a nebulized mixture of the radiopharmaceuticals Indium 111-DTPA and Technetium 99m sulfur colloid.

DRUG

inhaled hypertonic saline (7%)

nebulized hypertonic saline (7%)

DRUG

mannitol inhalation powder

mannitol inhalation powder

Trial Locations (1)

15213

University of Pittsburgh Medical Center, Pittsburgh

All Listed Sponsors
lead

Tim Corcoran

OTHER

NCT01887197 - Repeatability and Response Study of Absorptive Clearance Scans | Biotech Hunter | Biotech Hunter